Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 15476 - 15500 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Bortezomib	Approved Investigational	SFN	2810	upregulated	Bortezomib results in increased expression of SFN mRNA	1p36.11	A21434
Bortezomib	Approved Investigational	SFT2D3	84826	downregulated	Bortezomib results in decreased expression of SFT2D3 mRNA	2q14.3	A21434
Bortezomib	Approved Investigational	SGK1	6446	upregulated	Bortezomib results in increased expression of SGK1 mRNA	6q23.2	A21434
Bortezomib	Approved Investigational	SGMS1	259230	upregulated	Bortezomib results in increased expression of SGMS1 mRNA	10q11.23	A21434
Bortezomib	Approved Investigational	SGPP1	81537	upregulated	Bortezomib results in increased expression of SGPP1 mRNA	14q23.2	A21434
Bortezomib	Approved Investigational	SGSH	6448	upregulated	Bortezomib results in increased expression of SGSH mRNA	17q25.3	A21434
Bortezomib	Approved Investigational	SH2D3C	10044	downregulated	Bortezomib results in decreased expression of SH2D3C mRNA	9q34.11	A21434
Bortezomib	Approved Investigational	SH3GLB2	56904	downregulated	Bortezomib results in decreased expression of SH3GLB2 mRNA	9q34.11	A21434
Bortezomib	Approved Investigational	SHC1	6464	downregulated	Bortezomib results in decreased expression of SHC1 mRNA	1q21.3	A20714
Bortezomib	Approved Investigational	SIGMAR1	10280	downregulated	Bortezomib results in decreased expression of SIGMAR1 mRNA	9p13.3	A21434
Bortezomib	Approved Investigational	SIVA1	10572	downregulated	Bortezomib results in decreased expression of SIVA1 mRNA	14q32.33	A21437
Bortezomib	Approved Investigational	SLC10A7	84068	upregulated	Bortezomib results in increased expression of SLC10A7 mRNA	4q31.22	A21434
Bortezomib	Approved Investigational	SLC25A11	8402	downregulated	Bortezomib results in decreased expression of SLC25A11 mRNA	17p13.2	A21434
Bortezomib	Approved Investigational	SLC26A11	284129	upregulated	Bortezomib results in increased expression of SLC26A11 mRNA	17q25.3	A21434
Bortezomib	Approved Investigational	SLC2A3	6515	upregulated	Bortezomib results in increased expression of SLC2A3 mRNA	12p13.31	A21434
Bortezomib	Approved Investigational	SLC35C2	51006	downregulated	Bortezomib results in decreased expression of SLC35C2 mRNA	20q13.12	A21434
Bortezomib	Approved Investigational	SLC35G1	159371	downregulated	Bortezomib results in decreased expression of SLC35G1 mRNA	10q23.33	A21434
Bortezomib	Approved Investigational	SLC38A6	145389	upregulated	Bortezomib results in increased expression of SLC38A6 mRNA	14q23.1	A21434
Bortezomib	Approved Investigational	SLC43A3	29015	downregulated	Bortezomib results in decreased expression of SLC43A3 mRNA	11q12.1	A21434
Bortezomib	Approved Investigational	SLC7A5	8140	downregulated	Bortezomib results in decreased expression of SLC7A5 mRNA	16q24.2	A21434
Bortezomib	Approved Investigational	SMC1A	8243	downregulated	Bortezomib results in decreased expression of SMC1A mRNA	Xp11.22	A21434
Bortezomib	Approved Investigational	SMC3	9126	upregulated	Bortezomib results in increased expression of SMC3 mRNA	10q25.2	A21434
Bortezomib	Approved Investigational	SMC6	79677	upregulated	Bortezomib results in increased expression of SMC6 mRNA	2p24.2	A21434
Bortezomib	Approved Investigational	SMIM11A	54065	downregulated	Bortezomib results in decreased expression of SMIM11A mRNA	21q22.11-q22.12	A21434
Bortezomib	Approved Investigational	SMURF2	64750	upregulated	Bortezomib results in increased expression of SMURF2 mRNA	17q23.3-q24.1	A21434

Displaying entries 15476 - 15500 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability